Tanning caused by psoralenTanning caused by psoralenphotochemotherpy in Indian skin photochemotherpy in Indian skin Sir, One of the common side effects of psoralenphotochemotherapy is excessive tanning of the skin. We had an opportunity to observe the extent of tanning that can occur in an individual with pigmented skin due to sparing of some abnormal skin folds.
A 54-year-old man with immunohistologically proven stage Ia cutaneous T-cell lymphoma (CTCL) was receiving trimethylpsoralen and ultraviolet A (PUVA) therapy for past eight months. The patient was initially given 8-methoxypsoralen (8-MOP), but he complained of excessive itching with this. After four doses, 8-MOP was successfully replaced with trimethylpsoralen, which the patient tolerated well. He also had scoliosis of the spine secondary to poliomyelitis since childhood. Cutaneous lymphoma responded well to PUVA therapy with complete resolution of lesions, both clinically and histologically. He denied regular sun exposure/ sun bathing. There was no previous history of PUVA or ultraviolet B (UVB) therapy. He had received a total of 746 J/cm 2 of UVA over a period of eight months. One day, the patient noticed a few hypopigmented lesions on his trunk. Examination revealed diffusely tanned skin of the Fitzpatrick's skin phototype V over the trunk, face, and extremities. Due to the scoliosis, the posture of the patient was slightly tilted to the right side and, because of this, there were several folds of skin on the right side of his trunk secondary to the abnormal posture. On attaining a straight posture, the skin hided within the folds, became visible, and that was considerably lighter in color compared to the surrounding exposed skin. He was explained about the cause and assured that the change in skin color he was referring to as new lesions was normal skin color. Subsequently, four months after the discontinuation of the PUVA, the difference in color between the skin folds and exposed skin became less, though was still perceptible.
Though it is well known that PUVA causes hyperpigmentation, the extent of tanning that can be caused in pigmented skin has not been reported. In our patient, because of the abnormal skin folds on his trunk, the skin within the folds was completely protected from exposure to UV radiation in PUVA therapy. Hence it provided a direct comparison between two adjacent areas, one exposed to and the other protected from the PUVA therapy. Since the trunk is a nonexposed site and there was no history of sun bathing or occupation-related sun exposure, or previous UVA therapy, the changes in the skin type between the two areas of the skin was predominantly due to PUVA therapy.
The hyperpigmentation by PUVA is thought to be due to the stimulation of melanogenesis. Ultravioletinduced melanogenesis occurs through several distinct mechanisms involving the interaction of UVR with membrane lipids, keratinocytes, and DNA. There occurs photoconjugation of psoralens to DNA in melanocytes. Subsequent mitosis and proliferation of melanocytes, and increased formation and melanization of melanosomes to keratinocytes occurs. Also, there is activation and increased synthesis of tyrosine mediated by stimulation of cAMP activity. Pigmentation due to PUVA may develop without clinically evident erythema, especially when oral 5-methoxypsoralen or trimethylpsoralen (as in our patient) is used. [1] In normal skin, after a PUVA exposure, the pigmentation maximizes about one week after exposure. It may last for several weeks to months after discontinuation of PUVA. As seen with sun-induced pigmentation, the individual's ability to tan is genetically determined. A few PUVA exposures are known to produce a much deeper tan than that caused by multiple exposures to solar radiation. [2, 3] The tanning after solar exposure occurs in two stages: one is the immediate oxidation reaction in pre-existing melanin by UVA radiation (320-400 nm), and the other is the delayed tanning reaction by UVB as well as UVA. It involves increased tyrosinase activity and increased production of melanin by melanocytes. [3, 4] This mechanism may operate in PUVA-induced tanning also. On the one hand, understanding tanning induced by UVR is important, in addition to its intrinsic biological significance, because this pathway may lead to improvements in mechanism of photoprotection and generation of a tan without the deleterious effects of UVR. On the other hand, tanning may be undesirable and unacceptable side effect in pigmented people when photochemotherpy is given for therapeutic purposes.
The above case highlights the importance of explaining to the patients beforehand the amount of tanning PUVA may induce. It also highlights that in patients with CTCL receiving PUVA, there is a possibility of inadequate exposure of UVA to lesions located in skin folds in patients with abnormal posture or in obese patients, which may lead to relapse.
Concurrent oral and genital Concurrent oral and genital involvement in lichen planus involvement in lichen planus
Sir, The true incidence of lichen planus (LP) is unknown as it can affect one or several regions, can have various clinical appearances, and the diagnosis has to confirmed histopathologically. [1] Therefore, the true LP prevalence can be known only with the joint contributions of gynecologists, dentists, and dermatologists. [2] We selected patients with oral LP (OLP) and genital LP (GLP) lesions and tried to determine concurrent oral, genital, and skin involvements by engaging the cooperation of dermatologists, dentists, and pathologists.
Our study was performed on 38 LP patients who presented to the dermatology outpatient department with oral and/or genital mucosal involvements. All skin, oral, and genital region lesions were histopathologically evaluated and the LP diagnosis confirmed. The age range of these patients was 17-75 years with a mean age of 41.8 years. The disease duration varied between one month and 10 years with a mean value of 5.8 months. Of the 38 LP patients, there were skin lesions in 30 (78.9%), oral lesions in 29 (76.3%), and genital mucosal lesions in 27 (71.0%) [ Figures 1-3] . Five (13.1%) patients had exclusive oral mucosal involvement. The oral lesions were accompanied by skin lesions in 23 (60.5%) patients. There were both oral and genital involvements in 18 (47.4%) cases. Seventeen patients had concurrent oral, genital, and skin involvements. 
